Exploring lipophilic compounds that induce BDNF secretion in astrocytes beyond the BBB using a new multi-cultured human in vitro BBB model

J Neuroimmunol. 2022 Jan 15:362:577783. doi: 10.1016/j.jneuroim.2021.577783. Epub 2021 Dec 6.

Abstract

Brain-derived neurotrophic factor (BDNF) cannot cross the blood-brain barrier (BBB) when administered peripherally, which hinders its therapeutic potential. We utilized an in vitro BBB model-a tri-culture of a human endothelial cell line, a pericyte cell line, and an astrocyte cell line-to study the effect of twenty candidate lipophilic compounds on stimulating BDNF secretion in pericytes and astrocytes. The prostaglandin E2 receptor 4 agonist and sphingosine-1-phosphate receptor 5 agonist facilitated secretion of BDNF in the astrocyte, but did not decrease the transendothelial electrical resistance. These compounds may be promising agents for neurodegenerative and neuroinflammatory diseases.

Keywords: Astrocyte; Blood-brain barrier; Brain-derived neurotrophic factor; Pericyte; Prostaglandin E2 receptor 4 agonist; Sphingosine-1-phosphate receptor 5 agonist.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Astrocytes / metabolism*
  • Blood-Brain Barrier*
  • Brain-Derived Neurotrophic Factor / biosynthesis*
  • Cells, Cultured
  • Coculture Techniques / methods*
  • Humans
  • Receptors, Prostaglandin E, EP4 Subtype / agonists
  • Sphingosine-1-Phosphate Receptors / agonists

Substances

  • Brain-Derived Neurotrophic Factor
  • Receptors, Prostaglandin E, EP4 Subtype
  • Sphingosine-1-Phosphate Receptors
  • BDNF protein, human